Prismatomeris is a genus of the family Rubiaceae, which is mainly distributed in Southeast Asia. Some of the species were used to treat wounds, hepatitis, anemia, leukocythemia, pneumoconiosis, bronchitis, and as aphrodisiac. Up to now, the reported constituents from the genus Prismatomeris include anthraquinones, iridoids, and triterpenoids. Among them, anthraquinones, the characteristic components of this species become an intention due to their complex structures and significant biological features such as cytotoxic, antitumor, anticancer, antifungal, antimalarial, antiplasmodial, and antituberculosis activities. This review presents a systematic compilation of available data of secondary metabolites and their bioactivity studies of the genus Prismatomeris. It may lead to upcoming drug design, and therefore, provide a reference for advanced study and application of Prismatomeris.
INTRODUCTION
T he genus Prismatomeris (Rubiaceae) comprises about 25 species, being distributed in the tropical and subtropical areas in Southeast Asia. It is classified in the tribe of Morindeae, together with Morinda and Renellia; it seems closely allied to the latter genus. However, some researchers have classified it in a separate tribe; Prismatomerideae. [1] The genus Prismatomeris is a small shrub tree, with glossy pale brown bark flaking off when dry, and each internode with a median longitudinal ridge ending between each pair of leaf stalks. The leaves are ovate to elliptic or slightly obovate. Secondary veins are known to inarch to form a series of marginal loops while tertiary veins are reticulate or obscure. The stipules of the leaves are triangular, bifid at the tip and the apices are either look like two cusps or fine points. Its flowers are stalked or sessile, in terminal and axillary clusters of two to ten bisexual and heterostylous. The calyx cup fringed by four to six teeth or subtruncate. The color is white. The ovary is two-celled while ovules one per cell. It attached to ovary cross wall with filiform style and two-lobed stigma. The fruit is globose to ellipsoid with one or two seeded. The seeds are globose, with a narrow lateral groove at its point of attachment. [2] [3] [4] Previous phytochemical investigation of this genus was found to have anthraquinones, anthraquinone glycosides, iridoids, and triterpenoids. [5] [6] [7] [8] [9] [10] [11] [12] [13] The iridoids and triterpenoids are classified under the terpene groups while the anthraquinones are considered as phenolics. These compounds have shown cytotoxic, antitumor, anticancer, antifungal, antimalarial, antiplasmodial, and antituberculosis activities.
TRADITIONAL USES
In the traditional folklore medicine, Prismatomeris genus has been reported for the treatment of several ailments. In Peninsular Malaysia and Thailand traditional medicinal system, the leaves have been applied as a poultice to fresh wounds. The root of Prismatomeris connata has been used in traditional medicine in China for the treatment of hepatitis, anemia, leukocythemia, and pneumoconiosis. [2] The water decoction of the roots of Prismatomeris fragrans is used traditionally as a tonic. [3] In Thailand, the macerated roots in water are used to treat snakebites whereas, in Indochina, the decoction has been used in a mixture with coconut and henna to treat bronchitis. [4] In Malaysia, the aqueous extracts of the roots of Prismatomeris glabra have been used traditionally for wellness, enhancing stamina, and for its ergogenic effects. [16] In addition, as stated by a local taxonomist, this plant has been used as an aphrodisiac. The roots of Prismatomeris tetrandra were used as Chinese traditional medicine to treat leukocythemia, gum bleeding, hepatitis, and anemia. [17] 
PHYTOCHEMISTRY
Since the 1980s, compounds 1-67 [ Figure 1 ] were successfully isolated from Prismatomeris genus. Their structures, names, and the corresponding plant sources are discussed below. A literature survey revealed that only six species of Prismatomeris genus have been investigated worldwide which are, Prismatomeris connate, [7, 8, 12, 13, 18] P. fragrans, [15] P. glabra, [11, 19, 20] Prismatomeris malayana, [9] Prismatomeris sessiliflora, [5] and Prismatomeris tetrandra. [6, 10, 18, [20] [21] [22] Chemical investigations have been reporting the existence of anthraquinones, iridoids, phenols, triterpenoids, and phytosterols.
P. connata Y. Z. Ruan
P. connata is distributed in Hainan, China where the root is also known by the common name huang-gen and has been used in traditional herbal medicine. [4] Pharmacological studies showed that the roots possess antibacterial, anti-inflammatory, and antitumor activities. [23] The first phytochemical study of this plant appeared in literature in 2011 when Hao et al. isolated from the root extracts and structurally characterized six known anthraquinone glycosides. They were 1-O-methylrubiadin
, and digiferruginol ω-gentiobiose 6. Hydrolisis of 4 has afforded lucidin 7. [13] In the same year, Feng et al. obtained a new anthraquinone from root extracts; 4-hydroxy-1,2,3-trimethoxy-6-methylanthracene-9,10-dione 8, and two novel tetrahydroanthraquinones; prisconnatanones A 9 and B 10, together with 15 known anthraquinones which are, 1-hydroxy-2,3-dimethoxy-7-methyl-9,10-anthraquinone 11, 1,3-dihydroxy-2-methyl-anthraquinone 12, ibericin 13, lucidin ω-methyl ether 14, 1,3-dihydroxy-5,6-dimethoxy-2-methyl-9,10-anthraquinone 15, 3-hydroxy-1,5,6-trimethoxy-2-methyl-9,10-anthraquinone 16, 3-hydroxy-1-methoxy-2-methyl-9,10-anthraquinone 17, 2-methylanthraquinone 18, lucidin7, 2-methoxyanthraquinone 19, 1-methoxy-2-methylanthraquinone 20, 2-hydroxy-1-methoxyanth raquinone 21, 1,2,3-trimethoxy-7-methylanthr aquinone 22, 1,3-dihydroxy-5,6-dimethoxy-2-(methoxymethyl)-9,10-anthraquinone 23, and 6-methoxyibericin 24. [7] A year later, a further reinvestigation by the same researchers also of the root extracts has afforded a new phenolic glycoside, prismaconnatoside A 25, together with one phenolic glycoside, berchemolide 26 and four aspruloside type iridoid glycosides, aspruloside 27, asperulosidic acid 28, deacetylasperuloside 29, and deacetylasperulosidic acid 30. [18] 3 years later, Wang et al. managed to isolate seven new tetrahydroanthraquinones, prisconnatanones C-I 31-37 from the ethanol root extracts of P. connata. These new natural compounds belonged to the rare tetrahydroanthraquinone structural class. [12] P. fragrans E. T. Geddes P. fragransis a tree of 2-12 m in height found in the Northeastern, Eastern, and Southeastern parts of Thailand and the Northwest of Laos. [1] It is known as khao-san in Nakhon Phanom Province.
[3] The hexane and CH 2 Cl 2 extracts of airdried roots and stems of P. fragrans have been investigated by Kanokmedhakul et al. [15] They managed to isolate a new 1,3-dihydroxy-2-methyl-5,6-dimethoxyanthraquinone 38, six known anthraquinones; nordamnacanthal 39, damnacanthal 40, rubiadin 12, rubiadin-1-methyl ether 17, lucidin-ω-methyl ether 14, and 1-hydroxy-2-hydroxymethyl-3-methoxyanthraquinone 41; β-sitosterol42; together with two known triterpenoids; 3β-acetylolean-12-en-28-olic acid 43, and 3β-O-acetyl-11α,12α-epoxyolean-28,13-olide 44. Modification of compound 38 furnished the methyl ether derivatives 45.
P. malayana Ridley
P. malayanais a small tree up to 7 m tall and found indigenous to Western Malaysia. At the beginning of the 1960s, Lee described the isolation from root extracts and successfully identified rubiadin 12 and rubiadin-1-methyl ether 17. [24] Tuntiwachwuttikul et al. continued the investigation on this species and successfully isolated a novel anthraquinone, 1,3-dihydroxy-5,6-dimethoxy-2-methoxymethyl-9,10-anthraquinone 23 and a compound, 2-hydroxymethyl-1-methoxy-9,10-anthraquinone 46, along with seven known anthraquinones; tectoquinone 18, 1-hydr oxy-2-methyl-9,10-anthraquinone 47, rubiadin 12, rubiadin-1-methylether 17, 1,3-dihydroxy-5,6-dimethoxy-2-methyl-9,10-anthraquinone 38, nordamnacanthal 39, and damnacanthal 40. [9] Recently, Abdullah has investigated the phytochemical studies from the leaves, roots, and stems of P. malayana. The isolation work on the leaves, roots, and stems yielded ursolic acid 48, barbinervic acid 49, 3β,23-dihydroxyurs-12-en-28-oic acid 50, 28-O-β-glucopyranosyl-3α,19α,23-trihydroxyurs-12-en-28-oic acid 51, 3β-hydroxyurs-11-en-13,28-olide 52, asperulosidic acid 27, scandoside 53, prismalayanoside 54, 3β-hydroxyolean-12-en-28-O-acetoate 44, lucidin-3-methyl ether 55, rubiadin-1-methyl ether 17, damnacanthol 56, rubiadin 12, 1-ethyl-3-hydr oxymethyl-4-hydroxy-9,10-anthraquinone 57, 2-methoxy-3-oxyhydroxymethyl-9,10-anthraquinone 58, lucidin-ω-methyl ether 14, and asperuloside26. [25] P. tetrandra (Roxb) K. Schum P. tetrandra is locally known as tongkata jisamat and widely distributed in South East Asia such as India, Sri Lanka, Bangladesh, Vietnam, Thailand, and Peninsular Malaysia. The earliest report was by Tu et al. they have successfully isolatedtectoquinone 18, rubiadin 12, rubiadin-1-methyl ether 17, damnacanthal 40, β-sitosterol 42, ursolic acid 48, and daucosterol 62. [20] Feng et al. continued their phytochemical studies on this species and successfully identified three new anthraquinones; 1-hydroxy-2,3-dimethoxy-7-methyl-9,10-anthraquinone 11, 1,3-dihydroxy-5,6-dimethoxy-2-methyl-9,10-anthraquinone 38, and 3-hydroxy-1,5,6-trimethoxy-2-methyl-9,10-anthraquinone 63, together with five known compounds, namely 1-hydroxy-2-methyl-9,10-anthraquinone 47, 1,3-dihydroxy-2-methoxy-9,10-anthraquinone 27, 1,3-dihydroxy-2-methyl-9,10-anthraquinone 12, 3-hydroxy-1-methoxy-2-methyl-9,10-anthraquinone 17, and 2-hydroxy-3-hydroxymethyl-9,10-anthraquinone 64, from the root extracts. [6] In addition, Krohn et al. managed to isolate a new complex iridoid, prismatomerin 65, together with the known glucoside gaertneroside 66 from the leaves extracts. [14] Recently, Abdullah et al. had further investigated this species and obtained three pentacylic triterpenoids; namely ursolic acid 48, 3β,19,23-trihydroxyurs-12-en-28-oic acid 67, and 3β-acetylolean-12-en-28-oic acid 43. [26] P. glabra (Korth.) Valeton P. glabra is a tropical plant, grows on hillsides and ridges of tropical forests at altitudes up to 700 m in Peninsular Malaysia, Sumatra, and Borneo. [19, 27] Only one literature about this plant in 2013 when Mohamad et al. described the isolation of four anthraquinones, which are 1,3-dihydroxy-2-methoxymethyl-9,10-anthraquinone 14, 1-hydroxy-3-methoxy-2-(methoxymethyl)-9,10-anthraquinone 59, 2-methyl-3-methoxy-9,10-anthraquinone 60, and 1,3-dimethoxy-2-methyl-9,10-anthraquione 61. [11] P. sessiliflora Pierre ex Pitard P. sessiflora is a tree growing in Thailand, Laos, Cambodia, and Vietnam. This is the only report refers to the identification of rubiadin 12 and rubiadin-1-methyl ether 17 from the methanol extract of the roots. 
BIOLOGICAL ACTIVITIES Cytotoxicity Activity
Hao et al. have reported the cytotoxicity of the anthraquinone glycosides 1-7 isolated from P. connate using human lung cancer (A549) and human hepatoma (HepG2) cells grown in RPMI-1640 medium plus 10% heat-inactivated fetal bovine serum by MTT method. The aglycone7 of 4 exhibited a potent inhibitory effect on both A549 and HepG2 cell lines with IC 50 of 6.72 and 9.38 μmol/L, respectively. However, all six anthraquinone glycosides 1-6 nearly inactive (IC 50 >100 μmol/L) against the cell lines. Compound 9 exhibited potent cytotoxicity against the A549 and lung adenocarcinoma (LAC) human cancer cell lines with IC 50 values of 4.5 and 7.8 μM, respectively. [13] Compounds 13-16, 18, 23, and 24 showed inhibitory effects against A549 cell line with IC 50 values ranging from 16.1 to 93.6 μM and compounds 11-17, 18, 23, and 24 exhibited activities against LAC cell line with IC 50 values ranging from 9.6 to 99.1 μM. The activity profiles suggested that the phenolic OH group might be necessary for the antitumor potency of tetrahydroanthraquinones and anthraquinones. [7] The cytotoxicity of compounds 31-37 was tested in a panel of human lung tumor cells (H1229, HTB179, A549, and H520 cell lines). Compound 37 showed the strongest activity in the suppression of tumor cell growth (IC 50 2.7-3.9 µM) and the others with chelated phenolic hydroxyls exhibited relatively lower activity (IC 50 8-20 µM) . The activity profiles of these compounds may be due to the positions of hydroxyl groups at C-5 and C-8, which might be required for their antitumor potency, and hydroxylation at C-1 could significantly enhance its cytotoxic activity. [12] Compounds 39, 40, and 41 isolated from P. fragrans exhibited cytotoxic activity against breast cancer (BC) cell line with respective IC 50 values of 6.9, 10.1, and 8.0 µg/mL. In addition, compounds 38, 44, 39, 40, 12, 17, and 43 showed cytotoxic activities against NCIH187 cell line with IC 50 values of 8.7, 5.1, 1.9, 13.5, 14.2, 4.5, and 9.4 µg/mL, respectively. [15] Compounds 65 and 66 isolated from P. tetrandra were tested for cytotoxicity in the brine shrimp lethality assay. Both compounds showed remarkable toxicity (LD 50 72 ng/mL (195 μM) for 65 and 156 μg/mL (380 μM) for 66 at 24 h, and LD 50 below detection limit (all shrimps dead) for 65 and 92 μg/mL (224 μM) for 66 at 48 h. [14] Anticancer Activity
Compound 17 isolated from P. connate possesses good anticancer activity toward BC cell lines (IC 50 of 4.05 μg/mL) and was inactive against KB cell lines (IC 50 of 13.12 μg/mL), whereas compounds 17 and 40 were inactive for both cell lines (IC 50 of >20 μg/mL) (9) . Besides, compound 65 isolated from P. tetrandra was tested against NCI in an in vitro primary anticancer assay, a three-cell-line panel comprising MCF7 (BC), NCl-H460 (lung cancer), and SF-268 (central nervous system cancer). The cells showed zero growth in these tests in the presence of compound 65. [14] Antifungal Activity
The hexane and CH 2 Cl 2 extracts of air-dried roots and stems of P. fragrans exhibited antifungal activity toward Candida albicans with IC 50 values of 11-17 µg/mL. Compounds 39 and 40 showed antifungal activity towards C. albicans with IC 50 values of 6.0 and 22.6 µg/mL, respectively. [15] Both compounds also showed moderate activity against C. albicans with IC 50 values of 5.18 and 5.58 μg/mL, respectively, whereas compound 17 was inactive (IC 50 of >50 μg/mL).
[9]
Antimalarial Activity
The root methanol extract of P. sessiflora has shown significant antimalarial potential against T9/94 Plasmodium falciparum. In addition, compounds 12 and 17 which isolated from this species revealed weak activity with IC 50 range 1300 μg/mL and 1560 μg/mL, respectively. [3] Besides, compounds 17, 39, and 40 isolated from P. malayana did not show any antimalarial activity toward P. falciparum (IC 50 of >10 μg/mL). [9] Antiplasmodial Activity
The hexane and CH 2 Cl 2 extracts of air-dried roots and stems of P. fragrans exhibited antiplasmodial activity toward P. falciparum with IC 50 values of 3.1-3.7 µg/mL. Compound 43 isolated from this species was found to be active in this assay with an IC 50 value of 5.9 µg/mL. [15] Antitumor Activity
Compound 25 isolated from P. connata was examined for antitumor activity on human laryngocarcinoma HEp-2 cells in vitro and revealed that it is dramatically inhibited HEp-2 cell growth, induced the cell cycle arrest at the G2/M phase and efficiently induced cell apoptosis. [8] 
Antituberculosis Activity
Compounds 39, 40, 12, 41, and 43 which isolated from P. fragrans showed antituberculosis activity toward Mycobacterium tuberculosis with minimum inhibitory concentration (MIC) values of 100, 25, 100, 50, and 50 µg/mL, respectively. [15] 
Antimycobacterial Activity
The hexane and CH 2 Cl 2 extracts of air-dried root and stem of P. fragrans exhibited antimycobacterial activity toward M. tuberculosis with MIC values of 25-100 µg/mL. [15] 
CONCLUSION
In this review, we synopsizeon the secondary metabolites isolated from the genus Prismatomeris and their pharmacological properties. Most of the species produced anthraquinones, iridoids, and triterpenoids. Apart from that, further phytochemical studies are needed in the near future to provide a more detailed pattern of the natural constituents and the biologically active principles in extracts. As a conclusion, it is manifest that the genus Prismatomeris comprises therapeutically promising and valuable plants in the ethnomedical traditions. Meanwhile, few studies described its pharmacological properties, and this genus merits more intention in continuing research for new bioactive compounds.
